Committee for Medicinal Products for Human Use (CHMP): 15-18 September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 15 September 2025 to 18 September 2025
Annex to agenda of the CHMP meeting 15-18 September 2025
Agenda of the CHMP meeting 15-18 September 2025
Public call for expression of interest for experts to become members of the European Medicines Agency's Scientific Advisory Group on Immune and Inflammatory Diseases
Human medicines European public assessment report (EPAR): Thalidomide Lipomed, thalidomide, Date of authorisation: 19/09/2022, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 7, Status: Authorised
Network Portfolio Roadmap
PSUSA/00002398/202411
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 9-10 September 2025
Summary of opinion: Bravecto TriUNO, 10/09/2025 Positive